|
General Information
|
|
|
Product
|
GDF8 / Myostatin Peptide
|
|
Description
|
Antigenic Blocking Peptide Myostatin
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 325-375 on human Myostatin.
|
|
Accession #
|
GenBank: ABI48514
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q53S46
|
|
Overview
|
Acts specifically as a negative regulator of skeletal muscle growth.
|
|
Molecular Function
|
Cytokine activity; Growth factor activity; heparin binding; identical protein binding; receptor binding; transforming growth factor beta receptor binding
|
|
Subcellular Location
|
Secreted; cytoplasm
|
|
Structure
|
Homodimer; disulfide-linked (By similarity). Interacts with WFIKKN2, leading to inhibit its activity. Interacts with FST3. Belongs to the TGF-beta family.
|
|
Alternative Nomenclature
|
GDF 8 antibody
Growth differentiation factor 8 antibody
MSLHP antibody
MSTN antibody
myostatin antibody
|
| |
|
GDF8 / Myostatin Antibody
GDF8 / Myostatin Antibody FITC
GDF8 / Myostatin Antibody BIOTIN
GDF8 / Myostatin Positive Control
